469 related articles for article (PubMed ID: 29278873)
1. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
Wang D; Hao T; Pan Y; Qian X; Zhou D
Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
[TBL] [Abstract][Full Text] [Related]
5. The role of let-7 and HMGA2 in the occurrence and development of lung cancer: a systematic review and meta-analysis.
Li XX; Di X; Cong S; Wang Y; Wang K
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8353-8366. PubMed ID: 30556876
[TBL] [Abstract][Full Text] [Related]
6. LRH1 as a promising prognostic biomarker and predictor of metastasis in patients with non-small cell lung cancer.
Liu Y; Xing Y; Wang H; Yan S; Wang X; Cai L
Thorac Cancer; 2018 Dec; 9(12):1725-1732. PubMed ID: 30273983
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
9. PPM1D overexpression predicts poor prognosis in non-small cell lung cancer.
Yang H; Gao XY; Li P; Jiang TS
Tumour Biol; 2015 Mar; 36(3):2179-84. PubMed ID: 25412952
[TBL] [Abstract][Full Text] [Related]
10. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
11. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
12. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
13. mTOR and PTEN expression in non-small cell lung cancer: analysis by real-time fluorescence quantitative polymerase chain reaction and immunohistochemistry.
Wang L; Yue W; Zhang L; Zhao X; Wang Y; Xu S
Surg Today; 2012 May; 42(5):419-25. PubMed ID: 22127531
[TBL] [Abstract][Full Text] [Related]
14. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of 14-3-3γ overexpression in advanced non-small cell lung cancer.
Raungrut P; Wongkotsila A; Lirdprapamongkol K; Svasti J; Geater SL; Phukaoloun M; Suwiwat S; Thongsuksai P
Asian Pac J Cancer Prev; 2014; 15(8):3513-8. PubMed ID: 24870749
[TBL] [Abstract][Full Text] [Related]
16. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
[TBL] [Abstract][Full Text] [Related]
18. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.
Ni T; Mao G; Xue Q; Liu Y; Chen B; Cui X; Lv L; Jia L; Wang Y; Ji L
J Mol Histol; 2015 Oct; 46(4-5):325-35. PubMed ID: 26059795
[TBL] [Abstract][Full Text] [Related]
19. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
